02/12/2026
Amanda, our president, recently attended the Stand Up To Cancer (SU2C) Malignant Glioma Innovation Summit, where leading researchers, advocates, nonprofits, and industry partners came together with one urgent goal: accelerate breakthroughs for patients facing malignant gliomas.
One message was clear — no single institution can solve this alone. Collaboration is essential.
A powerful shift emerged from the discussions: malignant gliomas are not just isolated tumors, but complex, evolving ecosystems interacting with the brain. By bringing together neuroscience, immunology, epigenetics, and metabolism, researchers are uncovering new therapeutic pathways that may finally disrupt recurrence and treatment resistance.
This summit wasn’t an endpoint — it was a launchpad. The challenge is enormous, but so is the commitment to bold, patient-focused progress.
This is how paradigms shift. This is how we move closer to turning a devastating diagnosis into a curable disease.
Dragon Master Initiative is a 501(c)(3) celebrating over 10 years of using technology to speed the pace of cancer research and help to with the financial burden of a child traveling to specialized cancer treatments. Recognized by the White House as a Champion of Change for Precision Medicine.